Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 10,339 | 9,620 | 7,637 | 10,439 | 8,513 |
| Operating Income | -10,339 | -9,620 | -7,637 | -10,439 | -8,513 |
| Other Income | 1,275 | 1,254 | 1,111 | 1,014 | 193 |
| Pre-tax Income | -9,064 | -8,366 | -6,526 | -9,425 | -8,320 |
| Net Income Continuous | -9,064 | -8,366 | -6,526 | -9,425 | -8,320 |
| Net Income | $-9,064 | $-8,366 | $-6,526 | $-9,425 | $-8,320 |
| EPS Basic Total Ops | -0.21 | -0.19 | -0.15 | -0.04 | -0.37 |
| EPS Basic Continuous Ops | -0.21 | -0.19 | -0.15 | -0.04 | -0.37 |
| EPS Diluted Total Ops | -0.21 | -0.19 | -0.15 | -0.04 | -0.37 |
| EPS Diluted Continuous Ops | -0.21 | -0.19 | -0.15 | -0.04 | -0.37 |
| EBITDA(a) | $-10,828 | $-9,573 | $-8,175 | $-11,069 | $-8,499 |